Becton Dickinson vs Zocdoc

Side-by-side comparison of AI visibility scores, market position, and capabilities

Zocdoc leads in AI visibility (86 vs 80)
Becton Dickinson logo

Becton Dickinson

LeaderHealthcare Tech

Enterprise

Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.

AI VisibilityBeta
Overall Score
A80
Category Rank
#19 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
83
Gemini
85

About

Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.

Full profile
Zocdoc logo

Zocdoc

GrowthHealthTech

Patient Scheduling Marketplace

Zocdoc is a patient appointment booking marketplace that lets patients find and book in-network doctors in real time, with insurance verification and same-day availability filters.

AI VisibilityBeta
Overall Score
A86
Category Rank
#11 of 596
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
80
Gemini
92

About

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Patients can filter by specialty, insurance plan, location, and next available appointment, then book online in seconds — eliminating the phone-tag and hold-time historically required to schedule care. The platform verifies insurance acceptance in real time and sends automated reminders to reduce no-shows.

Full profile

AI Visibility Head-to-Head

80
Overall Score
86
#19
Category Rank
#11
77
AI Consensus
70
stable
Trend
stable
77
ChatGPT
88
83
Perplexity
80
85
Gemini
92
85
Claude
92
78
Grok
86

Key Details

Category
Enterprise
Patient Scheduling Marketplace
Tier
Leader
Growth
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Zocdoc
Patient Scheduling Marketplace

Integrations

Only Becton Dickinson
Becton Dickinson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.